Cargando…

Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer

Ovarian cancer remains the most lethal gynaecological cancer. A better understanding of the molecular pathogenesis of ovarian cancer is of critical importance to develop early detection tests and identify new therapeutic targets that would increase survival. Cancer cells depend on de novo lipid synt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pyragius, Carmen E., Fuller, Maria, Ricciardelli, Carmela, Oehler, Martin K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645713/ https://www.ncbi.nlm.nih.gov/pubmed/23574936 http://dx.doi.org/10.3390/ijms14047742

Ejemplares similares

Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
por: Ricciardelli, Carmela, et al.
Publicado: (2013)

Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis
por: Lokman, Noor A., et al.
Publicado: (2013)

Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance
por: Ricciardelli, Carmela, et al.
Publicado: (2017)

S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer
por: Noye, Tannith M., et al.
Publicado: (2018)

Exploring the Immunoproteome for Ovarian Cancer Biomarker Discovery
por: Martin, Karina, et al.
Publicado: (2011)

Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
por: Ween, Miranda P., et al.
Publicado: (2011)

Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian Cancer
por: Lokman, Noor A., et al.
Publicado: (2021)

Transforming Growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): A Matrix Protein with Dual Functions in Ovarian Cancer
por: Ween, Miranda P., et al.
Publicado: (2012)

Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
por: Macpherson, Anne M., et al.
Publicado: (2020)

A Comprehensive Molecular and Clinical Analysis of the piRNA Pathway Genes in Ovarian Cancer
por: Lee, Eunice, et al.
Publicado: (2020)

Chick Chorioallantoic Membrane (CAM) Assay as an In Vivo Model to Study the Effect of Newly Identified Molecules on Ovarian Cancer Invasion and Metastasis
por: Lokman, Noor A., et al.
Publicado: (2012)

Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
por: He, Jiangnan, et al.
Publicado: (2021)

Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines
por: Khetan, Riya, et al.
Publicado: (2022)

Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer
por: Lokman, Noor A., et al.
Publicado: (2019)

Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism
por: Leung, Dilys, et al.
Publicado: (2022)

ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome
por: Wang, Wanqi, et al.
Publicado: (2021)

Overexpression of piRNA Pathway Genes in Epithelial Ovarian Cancer
por: Lim, Shu Ly, et al.
Publicado: (2014)

4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer
por: Lokman, Noor A., et al.
Publicado: (2019)

Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
por: De Matteis, Serena, et al.
Publicado: (2018)

Reduced Gonadotrophin Receptor Expression Is Associated with a More Aggressive Ovarian Cancer Phenotype
por: Cheung, Janelle, et al.
Publicado: (2020)

Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer
por: Price, Zoe K., et al.
Publicado: (2023)

Aberrations in Lipid Expression and Metabolism in Psoriasis
por: Nowowiejska, Julia, et al.
Publicado: (2021)

Label-Free Quantification Mass Spectrometry Identifies Protein Markers of Chemotherapy Response in High-Grade Serous Ovarian Cancer
por: Arentz, Georgia, et al.
Publicado: (2023)

Targeting lipid metabolism in the treatment of ovarian cancer
por: Chaudhry, Saliha, et al.
Publicado: (2022)

Reducing the Invasiveness of Low- and High-Grade Endometrial Cancers in Both Primary Human Cancer Biopsies and Cell Lines by the Inhibition of Aquaporin-1 Channels
por: Khan, Sidra, et al.
Publicado: (2023)

Lipid Metabolism as a Therapeutic Target
por: Smith, Terry K., et al.
Publicado: (2012)

Disabled-2 (DAB2): A Key Regulator of Anti- and Pro-Tumorigenic Pathways
por: Price, Zoe K., et al.
Publicado: (2022)

Exosomes: Emerging Diagnostic and Therapeutic Targets in Cutaneous Diseases
por: Khan, Abdul Q., et al.
Publicado: (2020)

Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics
por: Cha, Ji-Young, et al.
Publicado: (2016)

Optical Fibre-Enabled Photoswitching for Localised Activation of an Anti-Cancer Therapeutic Drug
por: Palasis, Kathryn A., et al.
Publicado: (2021)

Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review
por: Cui, Meng-Ying, et al.
Publicado: (2022)

Aberrant MAPK Signaling Offers Therapeutic Potential for Treatment of Ovarian Carcinoma
por: Colic, Eva, et al.
Publicado: (2022)

Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Liver Lipidomics
por: Li, Zhao, et al.
Publicado: (2017)

Aberrant hepatic lipid storage and metabolism in canine portosystemic shunts
por: Van den Bossche, Lindsay, et al.
Publicado: (2017)

Lipid metabolism in tumor microenvironment: novel therapeutic targets
por: Liu, Xingkai, et al.
Publicado: (2022)

Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD
por: Vitulo, Manuela, et al.
Publicado: (2023)

Targeting Aquaporins in Novel Therapies for Male and Female Breast and Reproductive Cancers
por: Khan, Sidra, et al.
Publicado: (2021)

Targeting CDK9 for treatment of colorectal cancer
por: Rahaman, Muhammed H., et al.
Publicado: (2019)

Insights Into the Role of Mesothelin as a Diagnostic and Therapeutic Target in Ovarian Carcinoma
por: Shen, Jiayu, et al.
Publicado: (2020)

Lipid Regulatory Proteins as Potential Therapeutic Targets for Ovarian Cancer in Obese Women
por: Yang, Jing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ck8qou0h834o5cs11rfbb9ho2a